These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 497566)

  • 21. Aminoglycosides induce a phospholipidosis in the renal cortex of the rat: an early manifestation of nephrotoxicity.
    Feldman S; Wang MY; Kaloyanides GJ
    J Pharmacol Exp Ther; 1982 Mar; 220(3):514-20. PubMed ID: 7062263
    [No Abstract]   [Full Text] [Related]  

  • 22. Chlorcyclizine--induced pulmonary phospholipidosis in rats.
    Reasor MJ; Heyneman CA; Walker ER
    Res Commun Chem Pathol Pharmacol; 1982 Nov; 38(2):235-46. PubMed ID: 6131507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the alveolar macrophage in the induction of pulmonary phospholipidosis by chlorphentermine. II. Drug uptake into cells in vitro.
    Heyneman CA; Reasor MJ
    J Pharmacol Exp Ther; 1986 Jan; 236(1):60-4. PubMed ID: 3941401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drug-induced phospholipidosis - experimental and clinical aspects].
    Nässberger L
    Lakartidningen; 1982 Aug; 79(32-33):2777-9. PubMed ID: 7144360
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro assays and biomarkers for drug-induced phospholipidosis.
    Monteith DK; Morgan RE; Halstead B
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):687-96. PubMed ID: 17014389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phospholipidosis effect of drugs by adsorption into lipid monolayers.
    Ceccarelli M; Germani R; Massari S; Petit C; Nurisso A; Wolfender JL; Goracci L
    Colloids Surf B Biointerfaces; 2015 Dec; 136():175-84. PubMed ID: 26387069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting phospholipidosis using machine learning.
    Lowe R; Glen RC; Mitchell JB
    Mol Pharm; 2010 Oct; 7(5):1708-14. PubMed ID: 20799726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 96-well flow cytometric screening assay for detecting in vitro phospholipidosis-induction in the drug discovery phase.
    Natalie M; Margino S; Erik H; Annelieke P; Geert V; Philippe V
    Toxicol In Vitro; 2009 Mar; 23(2):217-26. PubMed ID: 19101623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-induced phospholipidosis.
    Lüllmann H; Lüllmann-Rauch R; Wassermann O
    Ger Med; 1973; 3(3-4):128-35. PubMed ID: 4370610
    [No Abstract]   [Full Text] [Related]  

  • 30. [Drug-induced phospholipidosis. An example of the use of NMR spectroscopy in pharmacologic research].
    Blaschke G; Seydel JK; Wassermann O
    Pharm Unserer Zeit; 1978 Jul; 7(4):105-14. PubMed ID: 684025
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug-induced phospholipidosis: are there functional consequences?
    Reasor MJ; Kacew S
    Exp Biol Med (Maywood); 2001 Oct; 226(9):825-30. PubMed ID: 11568304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging Mass Microscopy of Kidneys from Azithromycin-Treated Rats with Phospholipidosis.
    Sakurai T; Kamio K; Sasaki K; Nishimoto T; Yamaguchi JI; Sasaki M; Tsutsumi S
    Am J Pathol; 2018 Sep; 188(9):1993-2003. PubMed ID: 29981744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell-based fluorescence assay for evaluation of new-drugs potential for phospholipidosis in an early stage of drug development.
    Fujimura H; Dekura E; Kurabe M; Shimazu N; Koitabashi M; Toriumi W
    Exp Toxicol Pathol; 2007 Aug; 58(6):375-82. PubMed ID: 17408938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of chlorphentermine-induced pulmonary phospholipidosis in rats by phenobarbital.
    Reasor MJ; Davis ME
    Drug Metab Dispos; 1985; 13(2):192-6. PubMed ID: 2859167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A clinical flow cytometric biomarker strategy: validation of peripheral leukocyte phospholipidosis using Nile red.
    Halstead BW; Zwickl CM; Morgan RE; Monteith DK; Thomas CE; Bowers RK; Berridge BR
    J Appl Toxicol; 2006; 26(2):169-77. PubMed ID: 16278808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Drug-induced lipidosis: formation of myeloid bodies (author's transl)].
    Yamamoto A; Seki K; Kitani T; Matsuzawa Y; Adachi S
    Tanpakushitsu Kakusan Koso; 1974 Apr; 19(4):275-93. PubMed ID: 4369542
    [No Abstract]   [Full Text] [Related]  

  • 37. In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets.
    Fischer H; Atzpodien EA; Csato M; Doessegger L; Lenz B; Schmitt G; Singer T
    J Med Chem; 2012 Jan; 55(1):126-39. PubMed ID: 22122484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Immunohistochemical Investigation of Renal Phospholipidosis and Toxicity in Rats.
    Ma JY; Snook S; Garrovillo S; Johnson C; La D
    Int J Toxicol; 2017; 36(5):386-394. PubMed ID: 28820006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-induced phospholipidosis caused by combinations of common drugs in vitro.
    Glock M; Muehlbacher M; Hurtig H; Tripal P; Kornhuber J
    Toxicol In Vitro; 2016 Sep; 35():139-48. PubMed ID: 27221059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the alveolar macrophage in the induction of pulmonary phospholipidosis by chlorphentermine. I. Drug and phospholipid levels.
    Heyneman CA; Reasor MJ
    J Pharmacol Exp Ther; 1986 Jan; 236(1):55-9. PubMed ID: 3941400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.